ACM
IMVT icon

Aquatic Capital Management’s Immunovant IMVT Stock Holding History

Aquatic Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136,522
Closed -$2.18M – 1524
2025
Q2 		$2.18M Buy
136,522
+43,531
+47% +$658K 0.04% 452
2025
Q1 		$1.59M Buy
92,991
+45,343
+95% +$949K 0.04% 473
2024
Q4 		$1.18M Buy
+47,648
New +$1.35M 0.03% 504
2024
Q2 		– Sell
-52,000
Closed -$1.68M – 1404
2024
Q1 		$1.68M Buy
+52,000
New +$1.9M 0.05% 281
2023
Q3 		– Sell
-2,300
Closed -$44K – 1436
2023
Q2 		$44K Buy
+2,300
New +$42.9K ﹤0.01% 1014
2022
Q4 		– Sell
-2,000
Closed -$11K – 1580
2022
Q3 		$11K Buy
+2,000
New +$9.78K ﹤0.01% 1047
2022
Q2 		– Sell
-1,400
Closed -$8K – 1379
2022
Q1 		$8K Sell
1,400
-500
-26% -$3.11K 0.01% 724
2021
Q4 		$16K Buy
+1,900
New +$15.7K 0.03% 664

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Aquatic Capital Management's IMVT Position: Q3 2025 in Review

Aquatic Capital Management sold out of Immunovant (IMVT) in Q3 2025, closing a stake of 136,522 shares — an estimated $2.18M sold.

Aquatic Capital Management first reported a position in IMVT in Q4 2021 and held it in 8 quarters. The position peaked at $2.18M in Q2 2025. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

  • Aquatic Capital Management reported no remaining Immunovant position as of Q3 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 136,522 Immunovant shares in Q3 2025, an estimated $2.18M.
  • Aquatic Capital Management first reported a position in Immunovant in Q4 2021 and held it in 8 quarters.
  • Aquatic Capital Management's Immunovant position peaked at $2.18M in Q2 2025.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.